Peptide Associates Introduces Revolutionary GLP-3/Triple G Injection Model Focused on Direct Consumer Access
Sarasota, Florida – May 8, 2026 – Peptide Associates, a wellness-focused organization dedicated to advancing peptide-based solutions through innovation, today announced the introduction of its GLP-3/Triple G Injection model designed to expand structured access to metabolic wellness support through a direct-to-consumer inspired distribution framework. The new model reflects the company’s ongoing mission to modernize how […] Continue Reading

